Sjögren's syndrome patients who developed glomerulonephritis showed improvement with corticosteroid treatment. This treatment reduced circulating immune complexes, indicating a potential therapeutic target for kidney disease in Sjögren's syndrome.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Observation:
Findings:
Implications: